Publications found:
136
Sort by:
Cell & Gene Therapy Bioanalytical Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test Stage of Development), By Product Type ( Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Stage of Development (Non-Clinical, Clinical), By Indication ( Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cell & Gene Therapy Bioanalytical Testing Services Market is projected to grow significantly from USD 567.27 Million in 2025 to USD 961.36 Million by 2031, at a Compound Annual Growth Rate...
May 2026
188 pages
Peptide Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Lutetium, Melflufen, ANG1005, BT1718, CBX-12, Other Pipeline Products), By Type (Therapeutic, Diagnostic), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Peptide Drug Conjugates (PDCs) Market is projected for substantial growth, anticipating an increase from USD 671.02 Million in 2025 to USD 1464.36 Million by 2031, at a Compound Annual Grow...
May 2026
185 pages
Antibody Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Types (Monoclonal Antibodies, Linker, Drug/Toxin, Others), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Antibody Drug Conjugates Market is projected to grow from USD 8.39 Billion in 2025 to USD 12.18 Billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 6.41%. Antibody Drug Conj...
May 2026
185 pages
Aseptic Pharma Processing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Component (Processing Equipment {Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others} v/s Packaging Equipment {Inspection Machines, Labelling Machines, Aseptic Packaging Machines}), By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others), By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others), By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Aseptic Pharma Processing Market is projected to increase from USD 24.86 Billion in 2025 to USD 38.67 Billion by 2031, expanding at a CAGR of 7.64%. Aseptic processing involves sterilizing...
May 2026
182 pages
Virus Filtration Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Consumables {Kits and reagents, Others}, Instruments (Filtration systems, Chromatography systems), Services), By Technology (Filtration, Chromatography), By End Use (Biopharmaceutical & biotechnology companies, Contract research organizations, Academic institutes & research laboratories, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Virus Filtration Market is projected to expand from USD 5.78 Billion in 2025 to USD 9.52 Billion by 2031, registering a CAGR of 8.67%. This market consists of specialized size-exclusion tec...
May 2026
189 pages
Pharmaceutical Sterility Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (In-house, Outsourcing), By Product Type (Kits and Reagents, Instruments, Service), By Test Type (Sterility Testing, Membrane filtration, Direct inoculation, Bioburden Testing, Bacterial Endotoxin Testing), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for pharmaceutical sterility testing is projected to expand significantly, rising from USD 1.51 billion in 2025 to USD 2.78 billion by 2031, demonstrating a compound annual growth ra...
May 2026
185 pages
Biologics Regulatory Affairs Outsourcing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical, Trial Applications, Regulatory Submissions, Regulatory Operations, and Others), By Phase (Preclinical and Clinical), By Modality (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell & Gene Therapies, Biosimilars, and Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Biologics Regulatory Affairs Outsourcing Market is projected to expand from USD 2.59 Billion in 2025 to USD 4.26 Billion by 2031, exhibiting an 8.65% Compound Annual Growth Rate. This marke...
May 2026
180 pages
Biopharmaceutical Industry Market – Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Vaccines, Recombinant Enzymes, Cell and Gene Therapies, Synthetic Immunomodulators, Others), By Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Biopharmaceutical Industry Market is projected to expand significantly, growing from USD 456.13 Billion in 2025 to USD 738.42 Billion by 2031, demonstrating an 8.36% compound annual growth...
May 2026
180 pages
Large Molecule Bioanalytical Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Products & Services (Product (Consumables & Accessories, Instruments, Reagents & Kits), Service), By Application (Biologics, Oligonucleotide Derived Drugs & Molecules, Viral Vector, Cell & Gene Therapy, Nanoparticles & Polymers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for large molecule bioanalytical technologies is projected to expand significantly, from USD 9.73 billion in 2025 to USD 17.64 billion by 2031, demonstrating a compound annual growth...
May 2026
185 pages
Global Biopharmaceutical CDMO Market Size Study and Forecast by Type (API, Finished Drug Product), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Gene Therapy Products, Cell Therapy Products, Others), Service (Process Development, Analytical Testing, Manufacturing Services, Fill-Finish Services, Packaging & Labeling), Source (Mammalian Cells, Microbial Systems, Yeast Systems, Insect Cells, Others), Workflow (Upstream Processing, Downstream Processing, Fill-Finish Operations), Therapeutic Area (Oncology, Infectious Diseases, Autoimmune Disorders, Cardiovascular Diseases, Neurological Disorders, Others), End Use (Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Others), and Regional Forecasts 2026-2035
US$ 3,750.00
The global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO) market encompasses third-party service providers that support biotechnology and pharmaceutical companies in the...
April 2026
285 pages
Asia Pacific Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The Asia Pacific Biopharmaceutical Contract Manufacturing Market is poised for remarkable growth, projected to reach approximately US$ 26,544.2 million by 2031, up from US$ 10,448.9 million in 2024. T...
March 2026
176 pages
Europe Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), and Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others)
US$ 3,450.00
The Europe Biopharmaceutical Contract Manufacturing Market is projected to grow significantly, reaching an estimated US$ 27,678.2 million by 2031, up from US$ 11,420.5 million in 2024. This growth ref...
March 2026
177 pages
